Repligen Corporation (RGEN) Competitors & Peers
The 5 largest companies in the same industry as Repligen Corporation, by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ISRG | Peer | $383.54 | P/E 44.0RSI 55Cap 137.4 B |
| MDLN | Peer | $32.12 | P/E 40.1RSI 38Cap 28.2 B |
| BDX | Peer | $181.38 | P/E 31.4RSI 52Cap 49.4 B |
| ALC | Peer | $65.18 | P/E 49.5RSI 30Cap 31.3 B |
| RMD | Peer | $228.42 | P/E 21.9RSI 55Cap 33.0 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- GESupplier
Own 10-K customer-concentration disclosure: GeneralElectricHealthcare = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - BMRNSupplier
Own 10-Q customer-concentration disclosure: BiomarinPharmaceuticalIncorporated = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - DHRSupplier
Own 10-Q customer-concentration disclosure: Cytiva = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - PFESupplier
Own 10-Q customer-concentration disclosure: Pfizer = 11% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗